Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Oligometastatic Prostate Cancer × zimberelimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Uterine Cervical Neoplasms 6 Carcinoma, Non-Small-Cell Lung 4 Squamous Cell Carcinoma of Head and Neck 3 Lung Neoplasms 3 Stomach Neoplasms 2 Neoplasm Metastasis 2 Cholangiocarcinoma 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Urothelial Bladder Carcinoma 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thymoma 1 Sarcoma 1 Recurrence 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Oligometastatic Prostate Cancer 1 Neoplasms 1 Metastatic Urothelial Cancer 1 Melanoma 1 Locally Advanced Pancreatic Cancer 1 Locally Advanced Cervical Cancer 1 Liver Neoplasms 1 Liposarcoma 1 Kidney Neoplasms 1 Gestational Trophoblastic Disease 1 Gastro-enteropancreatic neuroendocrine tumor 1

Interventions

zimberelimab 1 quemliclustat 1 Radiosurgery 1 Androgen Antagonists 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05915442 2025-05-20

SBRT-AMICO

Columbia University

Phase 2 Recruiting

Oligometastatic Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡